Resultados de la búsqueda 1221-1230 of 4218 for AM - PM
... p.m. CDT; Researchers resolve uncertainty in BRCA2 testing, improving cancer ... 04, 2023, 11:00 a.m. CDT; Beyond BRCA1/2: Pinpointing the risk of inherited ...
... p.m. CDT; New study finds triple-negative breast cancer tumors with an ... 04, 2023, 11:00 a.m. CDT; Beyond BRCA1/2: Pinpointing the risk of inherited breast ...
... p.m. CDT; Mayo Clinic surgeon: Living kidney ... a.m. CDT; Mayo Clinic Minute: What is a living ... p.m. CDT; Transforming Transplant Initiative aspires ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies including large ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?